Literature DB >> 22065183

Impact of a more restrictive approach to urinary tract imaging after febrile urinary tract infection.

Alan R Schroeder1, Jennifer M Abidari, Rashmi Kirpekar, John R Hamilton, Young S Kang, VyThao Tran, Stephen J Harris.   

Abstract

OBJECTIVES: To determine the impact of using an algorithm requiring selective rather than routine urinary tract imaging following a first febrile urinary tract infection (UTI) on imaging use, detection of vesicoureteral reflux (VUR), prophylactic antibiotic use, and UTI recurrence within 6 months.
DESIGN: Retrospective review comparing outcomes during periods before algorithm use (September 1, 2006, to August 31, 2007) and after algorithm use (September 1, 2008, to August 31, 2009). The new algorithm, which adapted recommendations from the United Kingdom's National Institute for Health and Clinical Excellence 2007 guidelines, was implemented in 2008. The algorithm calls for renal ultrasonography in most cases and restricts voiding cystourethrography for use in patients with certain risk factors.
SETTING: County health system. PARTICIPANTS: Children younger than 2 years with a first febrile UTI. INTERVENTION: Selective algorithm for urinary tract imaging. MAIN OUTCOME MEASURES: Urinary tract imaging use, detection of VUR, prophylactic antibiotic use, and UTI recurrence within 6 months.
RESULTS: After introduction of the new algorithm, voiding cystourethrography and prophylactic antibiotic use decreased markedly. Rates of UTI recurrence within 6 months and detection of grades 4 and 5 VUR did not change, but detection of grades 1 to 3 VUR decreased substantially. Patients in the prealgorithm group with grades 1 to 3 VUR who would have been missed with selective screening underwent no interventions other than successive urinary tract imaging and prophylactic antibiotic use.
CONCLUSIONS: By restricting urinary tract imaging after an initial febrile UTI, rates of voiding cystourethrography and prophylactic antibiotic use decreased substantially without increasing the risk of UTI recurrence within 6 months and without an apparent decrease in detection of high-grade VUR. Clinicians can be more judicious in their use of urinary tract imaging.

Entities:  

Mesh:

Year:  2011        PMID: 22065183     DOI: 10.1001/archpediatrics.2011.178

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  7 in total

1.  Paediatric urology: rapid uptake of guidelines for imaging after first febrile UTI.

Authors:  Ian K Hewitt; Giovanni Montini
Journal:  Nat Rev Urol       Date:  2013-10-22       Impact factor: 14.432

2.  Do infants in the neonatal intensive care unit diagnosed with urinary tract infection need a routine voiding cystourethrogram?

Authors:  Dustin D Flannery; Erik Brandsma; Judy Saslow; Amy B Mackley; David A Paul; Zubair H Aghai
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-20

Review 3.  Relevance of current guidelines in the management of VUR.

Authors:  Alexander Springer; Ramnath Subramaniam
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

4.  Rapid implementation of evidence-based guidelines for imaging after first urinary tract infection.

Authors:  Karen E Jerardi; Dena Elkeeb; Jason Weiser; William B Brinkman
Journal:  Pediatrics       Date:  2013-08-19       Impact factor: 7.124

Review 5.  Update on recent guidelines for the management of urinary tract infections in children: the shifting paradigm.

Authors:  Elijah Paintsil
Journal:  Curr Opin Pediatr       Date:  2013-02       Impact factor: 2.856

6.  NICE guidelines for imaging studies in children with UTI adequate only in boys under the age of 6 months.

Authors:  Marko Tapani Ristola; Timo Hurme
Journal:  Pediatr Surg Int       Date:  2013-01-13       Impact factor: 1.827

7.  Culture-positive urinary tract infection following micturating cystourethrogram in children.

Authors:  Simeon Ngweso; Munyaradzi Nyandoro; Tatenda Nzenza; Ting Yi Cheow; Fiona Bettenay; Andrew Barker; Japinder Khosa; Naeem Samnakay
Journal:  Asian J Urol       Date:  2021-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.